Patients/Method: Twenty-seven adults who underwent an orchidopexy before 2 years of age have recently had their spermiograms analyzed. Results: Sixty-three percent of them had a normal sperm count; their germ cells had undergone the second stage of maturation and adult dark (Ad) spermatogonia were present at the time of surgery 20–25 years earlier. In contrast, 37% of them were infertile despite a seemingly successful orchidopexy; they had impaired second-step germ cell maturation and Ad spermatogonia were absent at orchidopexy. Conclusions: Transformation of gonocytes into Ad spermatogonia is crucial for fertility. This underscores the importance of a testicular biopsy at orchidopexy in order to identify those who could benefit from early LH-RH treatment after orchidopexy.

1.
Lee P: Fertility in cryptorchidism: Does treatment make a difference? Endocrinol Metab Clin N Am 1993;22:479–490.
2.
Guillon G: Frequency and causal relationship of prepubertal cryptorchidism in male hypofertility; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 505–515.
3.
Giarola A, Agostini G: Undescended testis and male fertility; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 533–536.
4.
Marina C: A study of cryptorchid subjects. Note 2: Evaluation of reproductive function following orchidopexy; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 549–555.
5.
Wojciechowski K, Rucki T, Sobeczynski S, Szymczynski G: A long-term follow-up study of surgical treatment of cryptorchidism; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 557–562.
6.
David G, Bisson JP, Martin-Boyce A, Feneux D: Sperm characteristics and fertility in previously cryptorchid adults; in Job JCl (ed): Cryptorchidism, Diagnosis and Treatment. Pediatr Adolesc Endocr. Basel, Karger, 1979, vol 6, pp 187–194.
7.
Chilvers C, Dudley NE, Gough MH, Jackson MB, Pike MC: Undescended testis: The effect of treatment on subsequent risk of subfertility and malignancy. J Pediatr Surg 1986;21:691–696.
8.
Yunis NS, Peterson RO, Rathauser F: Bilateral testicular biopsies in the study of cryptorchidism; in Brooks B (ed): Controversies in Pediatric Surgery. Austin, University of Texas Press, 1982, pp 1–24.
9.
Hadziselimovic F: Cryptorchidism. Adv Anat Embryol Cell Biol 1977;53:1–77.
10.
Hadziselimovic F: Cryptorchidism: Management and Implications. Berlin, Springer, 1983.
11.
Huff D, Hadziselimovic F, Snyder HM III, Blythe B, Duckett J: Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners. Eur J Pediatr 1993;152:S10–14.
12.
Holstein AF, Wartenberg H, Vossmeyer J: Zur Zytologie der prenatalen Gonadenentwicklung beim Menschen. Teil III. Z Anat Entwickl Gesch 1971;135:43–66.
13.
Seguchi H, Hadziselimovic F: Ultramikroskopische Untersuchungen am Tubulus seminiferus bei Kindern von der Geburt bis zur Pubertät. I. Spermatogonienentwicklung. Anat Anz 1974;68:133–148.
14.
Forest MG, Sizonenko PC, Cathland AM, Bertrand J: Hypophyseo-gonadal function in humans during the first year of life. J Clin Invest 1974;53:819–828.
15.
Siebert JR: Testicular weight in infancy (letter). J Pediatr 1982;100:835–836.
16.
Cassorla FG, Golden SM, Johsonbaugh RE, Hermon WM, Loriaux DL, Sherins RJ: Testicular volume during early infancy. J Pediatr 1981;99:742–743.
17.
Kaplan SL, Grumbach MM, Aubert ML: The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: Maturation of control nervous system regulation of interior pituitary function. Rec Prog Horm Res 1976;32:161–243.
18.
Gondos B: Development and differentiation of the testis and male reproductive tract; in Steinberger A, Steinberger E (eds): Testicular Development, Structure, and Function. New York, Raven Press, 1980, pp 3–15.
19.
Clermont Y: Renewal of spermatogonia in men. Am J Anat 1966;118:509–524.
20.
Hadziselimovic F, Thommen L, Girard J, Herzog B: The significance of postnatal gonadotropin surge for testicular development in normal and cryptorchid testes. J Urol 1986;136:274–276.
21.
Hadziselimovic F, Snyder HM, Huff D: Impaired gonocyte transformation due to androgen receptor defect. Pediatrics 1999;104:843–844.
22.
Hadziselimovic F, Herzog B: The meaning of the Leydig cell in relation to the etiology of cryptorchidism: An experimental electron-microscopic study. J Paediatr Surg 1976;11:1–8.
23.
Canlorbe P, Borniche P, Bader JC, Vassal J, Toublanc JE, Job J Cl: La cryptorchidie. Arch Fr Pédiatr 1974;31:145–156.
24.
Job J Cl, Garnier PE, Chaussain JL, Toublanc JE, Canlorbe P: Effect of synthetic LH-RH in hypophyso-gonadal disorders and adolescents. IV. Undescended testes. J Pediatr 1974;84:371–376.
25.
Waaler PE: Endocrinological studies in undescended testis. Acta Pediatr Stockh 1976;65:559.
26.
Battin J, Colle M: Hétérogenéité du syndrome cryptorchidie. Arch Fr Pédiat 1977;34:595–605.
27.
Bracci R, Maci D, Vanni MG, Vegni-Talluri M, Bigliardi E, Tota G, Martino A: Endocrinological studies in cryptorchidism; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 253–259.
28.
Jacobelli A, Agostino A, Vecci E, Simeoni A, Ferrantelli M: Studies on the pituitary-testicular axis in boys with cryptorchidism; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 261–268.
29.
Mazzi C, Riva LP, Morandi E, Scarasi G, Salaroli A: A study of cryptorchid subjects. I. Evaluations of the hypophyseal-testicular axis in the prepubertal boys; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 269–276.
30.
Krause W, Jenzen G, Rothauge CF: Endocrine studies in boys with cryptorchidism. Prog Reprod Biol Med. Basel, Karger, 1984, vol 10, pp 31–38.
31.
Hadziselimovic F: Cryptorchidism; in Retik A, Cukier J (eds): Pediatric Urology. Baltimore, Williams & Williams, 1987, pp 271–281.
32.
Gendrel D, Roger M, Job JC: Plasma gonadotropin and testosterone values in infants with cryptorchidism. J Pediatr 1980;97:217–220.
33.
Cacciari E, Gicognani A, Prazzoli P, Zappola F, Tassoni P, Bernardi F, Salardi S: Hypophysogonadal function in the cryptorchid children. Difference between unilateral and bilateral cryptorchidism. Acta Endocr Copenh 1976;83:182–193.
34.
Bartolini E, Galli P, Del Genevese A, Panichi A, Barletta D, Valicenti A, Silvestri D, Tronchetti F: Pituitary response to constant infusion of LH-RH in cryptorchid boys; in Bierich J, Giarola A (eds): Cryptorchidism. London, Academic Press, 1979, pp 351–357.
35.
DeMuinck Keizer-Schrama SMPF, Hazebrock FWJ: Treatment of Cryptorchidism. Why – How – When. Alblasserdam, Davids, 1986.
36.
Dunkel L: Pituitary-testicular responsiveness in normal boys and boys with hypogonadotropic hypogonadism; academic diss., Helsinki, 1985.
37.
Forest MG: Pattern of the response to HCG stimulation in prepubertal cryptorchid boys; in Job J Cl (ed): Cryptorchidism, Diagnosis and Treatment. Pediatr Adolesc Endocr. Basel, Karger, 1979, pp 108–120.
38.
Tamoki BI, Inano H, Makano H: In vitro studies and conversion in testicular tissue; in McKerns KW (ed): The Gonads. New York, Appleton Century Crofts, 1969.
39.
Rudd BT, Rayner PHW, Smith MR, Holder G, Jivani SKM, Theodoridis CG: Effect of HCG on plasma and urine testosterone in boys with delayed puberty. Arch Dis Child 1973;48:590–601.
40.
Walsh PC, Curry N, Mills R, Siiteri P: Plasma androgen response to HCG stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocr Metab 1976;42:52–59.
41.
Butenandt O, Knorr D: Maldescensus testis – Konservative Behandlungsmöglichkeiten. Dtsch Ärztebl 1977;28:1799–1802.
42.
Anoussakis C, Alexou D, Liakakos D, Skopelitis P: HCG stimulation test in prepubertal boys with cryptorchidism. J Pediatr 1978;93:630–632.
43.
Canlorbe P: Problems of cryptorchidism. Helv Pediatr Acta 1979;34:47–52.
44.
Toublanc JE, Gendrel D, Job Cl: Kryptorchismus beim Kind; in Schier F, Waldschmidt J (eds): Malescensus testis. München, Zuckschwerdt Verlag, 1988, pp 126–129.
45.
Hadziselimovic F, Girard J, Herzog B: Lack of germ cells and endocrinology in cryptorchid boys from one to six years of life; in Bierich J, Giarola A (eds): London, Academic Press, 1979, pp 129–134.
46.
Mann DR, Gould KG, Collins DC, Wallen K: Blockade of neonatal activation of the pituitary-testicular axis: Effect on peripubertal luteinizing hormone and testosterone secretion and testicular development in male monkeys. J Clin Endocrinol Metab 1989;68:600–607.
47.
Mann DR, Akinbambi MA, Gould KG, Tanner JM, Wallen K: Neonatal treatment of male monkeys with gonadotropin-releasing hormone agonist alters differentiation of central nervous system centers that regulate sexual and skeletal development. J Clin Endocrinol Metab 1993;76:1319–1324.
48.
Hadziselimovic F, Herzog B: Treatment with a luteinizing hormone releasing hormone analogue after successful orchidopexy markedly improves the chance of fertility later in life. J Urol 1997;158(suppl 342):1193–1195.
49.
Hadziselimovic F, Herzog B: Kryptorchismus; in Daum R, Mildenberger H, Rehbein F (eds): Hodenerkrankungen im Kindesalter. Stuttgart, Hippokrates, 1990, pp 24–73.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.